Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Daiichi Sankyo
Deloitte
Cantor Fitzgerald
Chinese Patent Office
Farmers Insurance

Generated: June 20, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR YASMIN

« Back to Dashboard

Clinical Trials for Yasmin

Trial ID Title Status Sponsor Phase Summary
NCT00185419 A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception Completed Bayer Phase 3 The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive Yasmin and Marvelon on cycle control in healthy Chinese women
NCT00367276 Study to Evaluate the Effect of Six Cycles of Treatment With a Combined Oral Contraceptive (EE 0.30 mg/DRSP 3 mg) on Quality of Life. Completed Bayer Phase 3 The purpose of this study is to evaluate the effects on the quality of life and BMI of new contraceptives.
NCT00413062 Efficacy and Safety Study of the Combined Oral Contraceptive NOMAC-E2 Compared to a COC Containing DRSP/EE (292002)(P05722) Completed Merck Sharp & Dohme Corp. Phase 3 The primary purpose of this study is to assess contraceptive efficacy, vaginal bleeding patterns (cycle control), general safety and acceptability of the nomegestrol acetate-estradiol (NOMAC-E2) combined oral contraceptive (COC) in a large group of women aged 18-50 years.
Trial ID Title Status Sponsor Phase Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Yasmin

Condition Name

Condition Name for Yasmin
Intervention Trials
Contraception 10
Polycystic Ovary Syndrome 7
Healthy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Yasmin
Intervention Trials
Polycystic Ovary Syndrome 8
Syndrome 6
Dysmenorrhea 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Yasmin

Trials by Country

Trials by Country for Yasmin
Location Trials
United States 14
Germany 10
Austria 5
Egypt 3
China 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Yasmin
Location Trials
Pennsylvania 2
California 2
Illinois 1
Washington 1
Texas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Yasmin

Clinical Trial Phase

Clinical Trial Phase for Yasmin
Clinical Trial Phase Trials
Phase 4 10
Phase 3 9
Phase 1 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Yasmin
Clinical Trial Phase Trials
Completed 21
Unknown status 3
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Yasmin

Sponsor Name

Sponsor Name for Yasmin
Sponsor Trials
Bayer 10
Merck Sharp & Dohme Corp. 2
Tyumen State Medical Academy 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Yasmin
Sponsor Trials
Other 16
Industry 15
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Healthtrust
Medtronic
Cipla
QuintilesIMS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.